These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 26651304

  • 21. A novel method for screening the multifocal electroretonogram in patients using hydroxychloroquine.
    Chang WH, Katz BJ, Warner JE, Vitale AT, Creel D, Digre KB.
    Retina; 2008; 28(10):1478-86. PubMed ID: 18997610
    [Abstract] [Full Text] [Related]

  • 22. Hydroxychloroquine and chloroquine retinopathy: a systematic review evaluating the multifocal electroretinogram as a screening test.
    Tsang AC, Ahmadi Pirshahid S, Virgili G, Gottlieb CC, Hamilton J, Coupland SG.
    Ophthalmology; 2015 Jun; 122(6):1239-1251.e4. PubMed ID: 25824328
    [Abstract] [Full Text] [Related]

  • 23. Risk of Retinal Toxicity in Longterm Users of Hydroxychloroquine.
    Kim JW, Kim YY, Lee H, Park SH, Kim SK, Choe JY.
    J Rheumatol; 2017 Nov; 44(11):1674-1679. PubMed ID: 28864645
    [Abstract] [Full Text] [Related]

  • 24. Hydroxychloroquine screening practice patterns within a large multispecialty ophthalmic practice.
    Au A, Parikh V, Modi YS, Ehlers JP, Schachat AP, Singh RP.
    Am J Ophthalmol; 2015 Sep; 160(3):561-568.e2. PubMed ID: 26116260
    [Abstract] [Full Text] [Related]

  • 25. Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision).
    Marmor MF, Kellner U, Lai TY, Melles RB, Mieler WF, American Academy of Ophthalmology.
    Ophthalmology; 2016 Jun; 123(6):1386-94. PubMed ID: 26992838
    [Abstract] [Full Text] [Related]

  • 26. The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal.
    Mavrikakis I, Sfikakis PP, Mavrikakis E, Rougas K, Nikolaou A, Kostopoulos C, Mavrikakis M.
    Ophthalmology; 2003 Jul; 110(7):1321-6. PubMed ID: 12867385
    [Abstract] [Full Text] [Related]

  • 27. [Clinical evaluation of the new screening procedures for hydroxychloroquine retinopathy, according to the American Academy of Ophthalmology guidelines. Prospective study of 184 patients].
    Jaumouillé S, Espargillière D, Mouriaux F, Mortemousque B.
    J Fr Ophtalmol; 2015 May; 38(5):377-87. PubMed ID: 25913441
    [Abstract] [Full Text] [Related]

  • 28. Effect of disease stage on progression of hydroxychloroquine retinopathy.
    Marmor MF, Hu J.
    JAMA Ophthalmol; 2014 Sep; 132(9):1105-12. PubMed ID: 24922444
    [Abstract] [Full Text] [Related]

  • 29. A comparison of structural and functional changes in patients screened for hydroxychloroquine retinopathy.
    Greenstein VC, Amaro-Quireza L, Abraham ES, Ramachandran R, Tsang SH, Hood DC.
    Doc Ophthalmol; 2015 Feb; 130(1):13-23. PubMed ID: 25502494
    [Abstract] [Full Text] [Related]

  • 30. Impact of Structural Changes on Multifocal Electroretinography in Patients With Use of Hydroxychloroquine.
    Borrelli E, Battista M, Cascavilla ML, Viganò C, Borghesan F, Nicolini N, Clemente L, Sacconi R, Barresi C, Marchese A, Miserocchi E, Modorati G, Bandello F, Querques G.
    Invest Ophthalmol Vis Sci; 2021 Sep 02; 62(12):28. PubMed ID: 34581725
    [Abstract] [Full Text] [Related]

  • 31. New trends in early diagnosis of hydroxychloroquine toxic retinopathy.
    Vanderzee G, Tassi D.
    Optometry; 2012 May 31; 83(5):200-7. PubMed ID: 23249122
    [Abstract] [Full Text] [Related]

  • 32. Multimodal imaging in a severe case of hydroxychloroquine toxicity.
    Bhavsar KV, Mukkamala LK, Freund KB.
    Ophthalmic Surg Lasers Imaging Retina; 2015 Mar 31; 46(3):377-9. PubMed ID: 25856825
    [Abstract] [Full Text] [Related]

  • 33. Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging.
    Mititelu M, Wong BJ, Brenner M, Bryar PJ, Jampol LM, Fawzi AA.
    JAMA Ophthalmol; 2013 Sep 31; 131(9):1187-97. PubMed ID: 23887202
    [Abstract] [Full Text] [Related]

  • 34. Correlation of macular structure and function in a boy with primary foveomacular retinitis and sequence of changes over 5 years.
    Badhani A, Padhi TR, Panda GK, Mukherjee S, Das T, Jalali S.
    Doc Ophthalmol; 2017 Aug 31; 135(1):43-52. PubMed ID: 28451988
    [Abstract] [Full Text] [Related]

  • 35. The Diagnostic Utility of Multifocal Electroretinography in Detecting Chloroquine and Hydroxychloroquine Retinal Toxicity.
    Tsang AC, Ahmadi S, Hamilton J, Gao J, Virgili G, Coupland SG, Gottlieb CC.
    Am J Ophthalmol; 2019 Oct 31; 206():132-139. PubMed ID: 31078540
    [Abstract] [Full Text] [Related]

  • 36. Recessive Stargardt disease phenocopying hydroxychloroquine retinopathy.
    Nõupuu K, Lee W, Zernant J, Greenstein VC, Tsang S, Allikmets R.
    Graefes Arch Clin Exp Ophthalmol; 2016 May 31; 254(5):865-72. PubMed ID: 26311262
    [Abstract] [Full Text] [Related]

  • 37. Retinal functional changes measured by frequency-doubling technology in patients treated with hydroxychloroquine.
    Tanga L, Centofanti M, Oddone F, Parravano M, Parisi V, Ziccardi L, Kroegler B, Perricone R, Manni G.
    Graefes Arch Clin Exp Ophthalmol; 2011 May 31; 249(5):715-21. PubMed ID: 21253758
    [Abstract] [Full Text] [Related]

  • 38. Retinal toxicity secondary to Plaquenil therapy.
    Hanna B, Holdeman NR, Tang RA, Schiffman JS.
    Optometry; 2008 Feb 31; 79(2):90-4. PubMed ID: 18215798
    [Abstract] [Full Text] [Related]

  • 39. Night Blindness, Ring Scotoma, and a Nonrecordable Electroretinogram in an Elderly Woman.
    Grassi MA, Maker MP, Marmor MF.
    JAMA Ophthalmol; 2019 Jan 01; 137(1):109-110. PubMed ID: 30452517
    [No Abstract] [Full Text] [Related]

  • 40. Normalization of generalized retinal function and progression of maculopathy after cessation of therapy in a case of severe hydroxychloroquine retinopathy with 19 years follow-up.
    Salu P, Uvijls A, van den Brande P, Leroy BP.
    Doc Ophthalmol; 2010 Jun 01; 120(3):251-64. PubMed ID: 20397038
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.